Friday , 20 September 2019


Stocks & ETFunds

The P/E Ratio: Its Strengths and Limitations (+26K Views)

When it comes to valuing stocks, the price-to-earnings (P/E) ratio is the number one metric for investors that want an instant fix on what the market thinks of a company. [That being said]...there are health warnings to heed if you don’t want to be left exposed by its limitations. [Let me explain.] Words: 1101

Read More »

BIG Differences In HUI, XAU, GDX & GDXJ Indicies (Almost 10K Views)

The number, market cap and currencies of the constituents of the HUI, XAU, GDX, XGD and CDNX indices differ considerably from each other and, as such, each index presents a different picture of what is really happening in the precious metals marketplace. This article analyzes the make-up of each index to reveal the biases of each to arrive at the answer to the question in the title. Words: 1026

Read More »

Don’t Be Misled: MAJOR Differences Exist Between HUI, XAU & other PM Indices (+7K Views)

The number, market cap and currencies of the constituents of the HUI, XAU, GDX, XGD and CDNX indices differ considerably from each other and, as such, each index presents a different picture of what is really happening in the precious metals marketplace. This article analyzes the make-up of each index to reveal the biases of each to arrive at the answer to the question in the title. Words: 1026

Read More »

Cannabis Central: Big Pharma Taking Over Medical Marijuana Industry

As evidence of cannabis’ many benefits mounts, so does the interest from the global pharmaceutical industry, known as Big Pharma. The entrance of such behemoths will radically transform the cannabis industry. Today’s infographic comes to us from CB2 Insights, and explores how and why the notorious Big Pharma are interested in the nascent cannabis industry.

Read More »